Thus, α5β1 integrin‐expressing cells, such as tumor and vascular cells, and PIR‐B‐expressing cells, such as dendritic cells, may compete for ANGPTL2 in the tumor microenvironment. The gene discussed is ANGPTL2; the disease is neoplasm.